Cargando…
The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?
Could new oral vaccine technologies protect endangered wildlife against a rising tide of infectious disease? We used captive chimpanzees to test oral delivery of a rabies virus (RABV) vectored vaccine against Ebola virus (EBOV), a major threat to wild chimpanzees and gorillas. EBOV GP and RABV GP-sp...
Autores principales: | Walsh, Peter D., Kurup, Drishya, Hasselschwert, Dana L., Wirblich, Christoph, Goetzmann, Jason E., Schnell, Matthias J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344013/ https://www.ncbi.nlm.nih.gov/pubmed/28277549 http://dx.doi.org/10.1038/srep43339 |
Ejemplares similares
-
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge
por: Yankowski, Catherine, et al.
Publicado: (2023) -
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity
por: Yankowski, Catherine, et al.
Publicado: (2022) -
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
por: Kurup, Drishya, et al.
Publicado: (2020) -
Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract
por: Kurup, Drishya, et al.
Publicado: (2022) -
Rabies-based vaccine induces potent immune responses against Nipah virus
por: Keshwara, Rohan, et al.
Publicado: (2019)